JCR Pharmaceuticals Co., Ltd., a specialty pharmaceuticals company, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V. Infusion used for the treatment of Fabry disease; and TEMCELL HS Inj used to treat acute graft-versus-host disease. The company also develops Epoetin Alfa BS and Darbepoetin Alfa BS Injections for the treatment of renal anemia. In addition, it sells medical devices and laboratory instruments. JCR Pharmaceuticals Co., Ltd. was incorporated in 1975 and is headquartered in Ashiya, Japan.
JCR Pharmaceuticals Dividend Announcement
• JCR Pharmaceuticals announced a semi annually dividend of ¥10.00 per ordinary share which will be made payable on 2025-06-01. Ex dividend date: 2025-03-28
• JCR Pharmaceuticals's trailing twelve-month (TTM) dividend yield is 2.74%
JCR Pharmaceuticals Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2025-03-28 | ¥10.00 | semi annually | 2025-06-01 |
2024-09-27 | ¥10.00 | semi annually | 2024-12-06 |
2024-03-28 | ¥10.00 | semi annually | |
2023-09-28 | ¥10.00 | semi annually | 2023-12-08 |
2023-03-30 | ¥10.00 | semi annually | 2023-06-22 |
2022-09-29 | ¥10.00 | semi annually | 2022-12-09 |
2022-03-30 | ¥2.00 | semi annually | 2022-06-23 |
2021-09-29 | ¥10.00 | semi annually | 2021-12-10 |
2021-03-30 | ¥0.50 | semi annually | 2021-06-24 |
2020-09-29 | ¥72.00 | semi annually | 2020-12-10 |
2020-03-30 | ¥17.00 | semi annually | 2020-06-25 |
2019-09-27 | ¥15.00 | semi annually | 2019-12-10 |
2019-03-27 | ¥17.00 | semi annually | 2019-06-28 |
2018-09-26 | ¥13.00 | semi annually | 2018-12-10 |
2018-03-28 | ¥14.00 | semi annually | 2018-06-28 |
2017-09-27 | ¥12.00 | semi annually | 2017-12-08 |
2017-03-29 | ¥12.00 | semi annually | 2017-06-29 |
2016-09-28 | ¥10.00 | semi annually | |
2016-03-29 | ¥2.00 | semi annually | |
2015-09-28 | ¥10.00 | semi annually | |
2015-03-27 | ¥10.00 | semi annually | |
2014-09-26 | ¥8.50 | semi annually | |
2014-03-27 | ¥3.00 | semi annually |
JCR Pharmaceuticals Dividend per year
JCR Pharmaceuticals Dividend growth
JCR Pharmaceuticals Dividend Yield
JCR Pharmaceuticals current trailing twelve-month (TTM) dividend yield is 2.74%. Interested in purchasing JCR Pharmaceuticals stock? Use our calculator to estimate your expected dividend yield:
JCR Pharmaceuticals Financial Ratios
JCR Pharmaceuticals Dividend FAQ
Other factors to consider when evaluating JCR Pharmaceuticals as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy JCR Pharmaceuticals stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: JCR Pharmaceuticals's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, JCR Pharmaceuticals publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, JCR Pharmaceuticals distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from JCR Pharmaceuticals are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: JCR Pharmaceuticals sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, JCR Pharmaceuticals distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: JCR Pharmaceuticals declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of JCR Pharmaceuticals's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review JCR Pharmaceuticals's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.